Suppr超能文献

三齿卤素取代席夫碱的细胞毒性氧化钒(IV)配合物:首例具有O→V=O→V=O核心的双核V(IV)配合物。

Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V = O → V = O core.

作者信息

Rudbari Hadi Amiri, Saadati Arezoo, Aryaeifar Mahnaz, Correia Isabel, Marques Fernanda, Blacque Olivier, Micale Nicola

机构信息

Department of Chemistry, University of Isfahan, Isfahan 81746-73441, Iran.

Department of Chemistry, University of Isfahan, Isfahan 81746-73441, Iran.

出版信息

Bioorg Med Chem Lett. 2021 Oct 1;49:128285. doi: 10.1016/j.bmcl.2021.128285. Epub 2021 Jul 23.

Abstract

The reaction of potentially N,N,O-tridentate Schiff base ligands, Cl-LH, Br-LH, BrCl-LH and H-LH, with [VO(acac)] in 2:1 ratio in methanol gave the corresponding mononuclear and dinuclear oxidovanadium(IV) complexes, VO(Cl-L) (1), VO(Br-L) (2), [(BrCl-L)(HO)V(μ-O)VO(BrCl-L)] (3) and [(H-L)(HO)V(μ -O)VO(H-L)] (4), in good yields. The ligands and complexes were fully characterized by elemental analysis and FT-IR spectroscopy. The ligands were also characterized by H NMR spectroscopy. The oxidation state of V(IV)O with d configuration in all synthesized complexes was confirmed by EPR. Moreover, the structures of 2 and 3 were determined by X-ray diffraction (XRD) analysis which revealed them as mono- and dinuclear vanadium(IV) complexes, respectively, with the ligands coordinated as bidentate chelates. The structure of 3 represents the first example of dinuclear V(IV) complex with O → V = O → V = O core (Cambridge Structural Database (CSD)​, version 5.42, update of May 2021). The cytotoxicity of ligands and complexes was evaluated towards ovarian (A2780), breast (MCF7) and prostate (PC3) cancer cells at 48 h. While ligands showed modest IC values (>42 μM), all complexes turned out to be effective in the range 3.9-17.2 μM. In particular, A2780 and MCF7 cell lines were the most sensitive to the newly synthesized V(IV)O complexes.

摘要

潜在的 N,N,O-三齿席夫碱配体 Cl-LH、Br-LH、BrCl-LH 和 H-LH 与 [VO(acac)] 在甲醇中以 2:1 的比例反应,以良好的产率得到了相应的单核和双核氧化钒(IV) 配合物 VO(Cl-L) (1)、VO(Br-L) (2)、[(BrCl-L)(HO)V(μ-O)VO(BrCl-L)] (3) 和 [(H-L)(HO)V(μ -O)VO(H-L)] (4)。通过元素分析和傅里叶变换红外光谱对配体和配合物进行了全面表征。配体还通过核磁共振氢谱进行了表征。通过电子顺磁共振证实了所有合成配合物中具有 d 构型的 V(IV)O 的氧化态。此外,通过 X 射线衍射 (XRD) 分析确定了 2 和 3 的结构,结果表明它们分别为单核和双核钒(IV) 配合物,配体以双齿螯合物的形式配位。3 的结构代表了具有 O→V=O→V=O 核心的双核 V(IV) 配合物的第一个实例(剑桥结构数据库 (CSD),版本 5.42,2021 年 5 月更新)。在 48 小时时评估了配体和配合物对卵巢癌 (A2780)、乳腺癌 (MCF7) 和前列腺癌 (PC3) 细胞的细胞毒性。虽然配体显示出中等的 IC 值(>42 μM),但所有配合物在 3.9-17.2 μM 范围内都被证明是有效的。特别是,A2780 和 MCF7 细胞系对新合成的 V(IV)O 配合物最敏感。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验